Assessing Untreated AML Patients Who Are Ineligible for Intensive Chemotherapy
https://vimeo.com/792474641 How are acute myeloid leukemia (AML) patients assessed for intensive chemotherapy? Dr. Catherine Lai from Penn Medicine explains eligibility criteria. Learn factors that impact patient eligibility and treatment options…
What AML Treatment Options Are Available for MRD-Positive Patients?
https://vimeo.com/792474010 For acute myeloid leukemia (AML) patients who are MRD-positive, what treatment options are available? Dr. Catherine Lai from Penn Medicine discusses MRD-positive concerns. Learn about recent guideline updates for…
What Is MRD-Positive Acute Myeloid Leukemia?
https://vimeo.com/792473929 What do acute myeloid leukemia (AML) patients need to know about MRD-positive AML? Dr. Catherine Lai from Penn Medicine discusses minimal residual disease (MRD). Learn about the meaning of…
What Is FLT3-Mutated Acute Myeloid Leukemia?
https://vimeo.com/792473811 Some acute myeloid leukemia (AML) patients may have an FLT3 mutation. Dr. Catherine Lai from Penn Medicine shares insight about the two types of FLT3 mutation, treatment options for…
What Are the Latest Acute Myeloid Leukemia Therapies?
https://vimeo.com/792473744 What are the latest treatments in acute myeloid leukemia (AML)? Dr. Catherine Lai from Penn Medicine discusses the increase in available AML treatments. Learn about combination therapies and treatment…
[ACT]IVATED AML Resource Guide
Download Resource Guide Download Resource Guide See More from [ACT]IVATED AML Share Your Feedback Create your own user feedback survey
INSIST! on Better AML Care Resource Guide
Download Guide Download Guide See More from INSIST! AML
Does Maintenance Therapy Have a Role in AML Care?
https://vimeo.com/777492990 Acute myeloid leukemia (AML) expert Dr. Farhad Ravandi-Kashani discusses the role of new and developing maintenance therapies that may improve remission and how this treatment phase may fit into…
Advances in AML Research | Where Do Clinical Trials Fit In?
How do clinical trials advance acute myeloid leukemia (AML) research? Dr. Farhad Ravandi-Kashani discusses newer AML treatments that have changed the landscape of care and how patient trial participation moves…
How Does the Presence of Molecular Markers Affect AML Care?
https://vimeo.com/777492887 Dr. Farhad Ravandi-Kashani reviews how the presence of gene mutations can influence acute myeloid leukemia (AML) treatment choices and discusses new molecular markers being researched for future AML care….
Diagnosing and Treating AML: What Testing Is Essential?
https://vimeo.com/777493136 How do test results affect the diagnosis and care of patients with acute myeloid leukemia (AML)? Dr. Farhad Ravandi-Kashani reviews essential testing for AML patients, including molecular testing and…
The Benefits of Being Pro-Active in Your AML Care
https://vimeo.com/769063234 Dr. Eytan Stein, an AML expert, discusses the importance of communicating regularly with your healthcare team and shares what makes him hopeful about the future of AML care. Dr….